Lonza | LONN - Sales Revenues



Lonza reported CHF3.58B in Sales Revenues for its fiscal semester ending in June of 2025.


Sales Change Date
Akzo Nobel EUR 2.63B 20M Jun/2025
Alcon AG USD 2.58B 130M Jun/2025
Almirall EUR 275M 9.6M Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
BASF EUR 15.77B 1.63B Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Beiersdorf EUR 2.5B 190M Jun/2025
Covestro EUR 3.38B 90M Jun/2025
Demant DKK 5.63B 10M Jun/2025
Fresenius EUR 5.58B 70M Jun/2025
Fresenius Medical Care EUR 4.79B 90M Jun/2025
Geberit CHF 878.5M 193.2M Mar/2025
Genmab DKK 5.86B 580M Jun/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 7.99B 470M Jun/2025
GN Store Nord DKK 4.16B 170M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Johnson Matthey GBP 6.04B 408M Mar/2025
Merck EUR 4.43B 850M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Philips EUR 4.34B 241M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.99B 90M Jun/2025
Sika AG CHF 5.93B 93M Dec/2024
Smith & Nephew USD 1.55B 140M Jun/2025
Solvay EUR 1.1B 20M Jun/2025
UCB EUR 3.49B 129M Jun/2025